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Abstract
Introduction Microvascular dysfunction causing intravascular
leakage of fluid and protein contributes to hypotension and
shock in sepsis. We tested the hypothesis that abrogation of
inducible nitric oxide synthase (iNOS) activation would
decrease leukocyte rolling, leukocyte adhesion, and
microvascular leakage in sepsis. We compared wild-type mice
made septic by cecal ligation and puncture with mice deficient
in iNOS.
Methods Leukocyte dynamics and microvascular permeability
were assessed simultaneously by fluorescence intravital
microscopy in the cremaster muscle 15 to 20 hours after
induction of sepsis by cecal ligation and puncture in C57Bl/6
mice. Rolling and adhesion of leukocytes labeled with
rhodamine and leakage of fluorescein isothiocyanate-
conjugated albumin was measured in single nonbranching
venules (25 to 40 μm) and compared among septic wild-type,
septic iNOS-deficient transgenic, and sham-operated control
mice.
Results Leukocyte rolling and adhesion were increased in
septic animals (61.6 ± 14.4 cells/minute and 4.1 ± 0.6 cells/
100  μm per minute, respectively) as compared with control
animals (8.5 ± 2.3 cells/minute and 1.1 ± 0.2 cells/100 μm per
minute, respectively; P < 0.001 for both). Rolling increased in
iNOS-deficient septic mice (to 105.5 ± 30.0 cells/minute, P =
0.048, versus wild-type septic); adhesion was unchanged (5.1
± 0.5 cells/100 μm per minute, P = 0.30). Sepsis produced an
increase in leakage ratio in wild-type septic mice compared with
controls (0.36 ± 0.05 versus 0.08 ± 0.01, P < 0.001). Leakage
was attenuated in iNOS-deficient septic mice (0.12 ± 0.02, P <
0.001, versus wild-type septic mice).
Conclusion Leukocyte adhesion and vascular leakage were
discordant in this setting. The finding that septic iNOS-deficient
mice exhibited less microvascular leakage than wild-type septic
mice despite equivalent increases in leukocyte adhesion
suggests an important role for nitric oxide in modulating vascular
permeability during sepsis.
Introduction
The most important pathophysiological abnormalities in sepsis
and other severe inflammatory conditions occur at the microv-
ascular level. These abnormalities include persistent vasodila-
tion refractory to vasopressors, activation of leukocytes
resulting in oxidative stress, inflammation, and the potential for
capillary plugging, increased microvascular leakage, platelet
activation and microthrombus formation, and microvascular
shunting.
The postcapillary venules are the primary site of inflammatory
events, which include neutrophil adhesion and emigration as
well as protein and water leakage. Endothelial-directed recruit-
ment and activation of neutrophils at the site of infection to
eradicate pathogens is a central feature of the innate immune
response to infection. The upregulation of adhesion molecules
by proinflammatory mediators becomes widespread in severe
sepsis, occurring not only at the site of infection but also
throughout the vasculature. As such, neutrophils can adhere
to and damage endothelium in noninfected tissues, contribut-
ing to the multiorgan failure characteristic of severe sepsis
[1,2].
Many of the effects of inflammatory cytokines elaborated dur-
ing sepsis are mediated through nitric oxide (NO), which is an
important regulator of vascular tone, leukocyte adhesion to
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microvascular endothelium, and capillary leakage. Activation of
the cytokine-inducible nitric oxide synthase isoform (iNOS),
with consequent over-production of NO, has been well docu-
mented in both animal models of sepsis and in septic patients,
and leads to vasodilation and pressor refractoriness [3-6].
Recent investigations have suggested that iNOS activity may
be compartmentalized at the site of infection and parallels
expressions of inflammatory cytokines [7]. Endothelium-
derived NO produced by the constitutive NOS isoform, how-
ever, is an important endogenous inhibitor of leukocyte adhe-
sion to the microvascular endothelium [8].
We hypothesized that abrogation of iNOS activation would
decrease leukocyte rolling, leukocyte adhesion, and microvas-
cular leakage in sepsis. To test this hypothesis, we compared
wild-type mice made septic by cecal ligation and puncture
(CLP) with knockout mice deficient in iNOS.
Materials and methods
The study was performed in accordance with US National
Institutes of Health (NIH) guidelines for the use of experimental
animals, and the protocol was approved by the institutional
Animal Care and Use Committee. Animals were made septic
by cecal ligation and puncture, and microvascular responses
were assessed using in vivo videomicroscopy.
Cecal ligation and puncture
Sepsis was induced surgically by CLP as previously described
[9,10]. Wild-type C57/BL6 and iNOS-deficient transgenic
C57/BL6 mice [11] were anesthetized for laparotomy. The
cecum was ligated and punctured with an 18-gauge needle.
For sham operations, laparotomy was performed but ligation
and puncture omitted. Animals were given normal saline 100
ml/kg subcutaneously after the procedure.
Videomicroscopy
Mice were prepared for videomicroscopic observations 12 to
15 hours after CLP. The mice were anesthetized with inhaled
isoflurane and the carotid artery cannulated for measurement
of blood pressure and intra-arterial infusion. The mice were
pretreated with cromolyn sodium 5 mg/kg intra-arterially to
prevent mast cell degranulation and histamine release [12].
The cremaster muscle was dissected and exteriorized onto an
optically clear viewing platform with blood and nerve supplies
preserved and suffused with physiologic Krebs solution
[10,13]. The preparation was placed on a custom-designed
platform on the stage of an upright microscope and the transil-
luminated microcirculation was viewed through a 40× objec-
tive. The image was projected by videocamera onto a monitor
and recorded on a video cassette recorder. Single
unbranched postcapillary venules (20 to 40 μm in diameter,
250 μm long) were selected for study. Venular diameter was
measured off-line using a frame grabber and NIH-Image anal-
ysis program (NIMH, Bethesda, MD, USA). Mean red blood
cell velocity was measured using an optical Doppler velocime-
ter (Microcirculation Research Institute, Texas A&M University,
College Station, TX, USA), which uses a pair of photodiodes
to generate a voltage from an image of moving red cells that is
a linear representation of red cell velocity [14]. Wall shear rate
was calculated based on the Newtonian definition as (mean
red blood cell velocity/diameter) × 8 (seconds-1) [15].
Experimental protocol
After the preparation was in place, 60 minutes were allowed
for it to reach a steady state. Single unbranched postcapillary
venules (20 to 30 μm in diameter, 250 μm long) were selected
for study. Leukocytes were labeled with rhodamine 6G (5 mg/
kg) given intra-arterially to facilitate visualization, and imaged
with a rhodamine cube in a Nikon E600 fluorescence micro-
scope. The number of rolling and adherent leukocytes was
determined by offline playback of videotaped images. Leuko-
cytes were considered to be rolling if they were moving more
slowly than red blood cells. The rolling rate was expressed as
the number of cells moving past a designated point per minute
(leukocyte flux) [8,15]. A leukocyte was defined as adherent to
venular endothelium if it remained stationary for longer than 30
seconds. Adherent cells were expressed as the number per
100 mm length of the venule per minute [12,16,17].
To quantify albumin leakage across cremasteric postcapillary
venules, 50 mg/kg fluorescein isothiocyanate-labeled albumin
(Sigma Chemical Co, St Louis, MO, USA) was administered
intra-arterially and fluorescence intensity detected using a SIT
camera (Hamamatsu, Hamamatsu City, Japan). The fluores-
cence intensity of fluorescein isothiocyanate-albumin within
three segments of the venule under study (Vi) and in three con-
tiguous areas of perivenular interstitium (Vo) equally spaced
from the midline of the vessel (at 40 μm and 60 μm on each
side) was measured at 10 minutes, averaged, and leakage
indexed as Vo/Vi [18].
Four groups of animals were studied: sham-operated control
mice (n = 8), sham-operated iNOS-deficient mice (n = 8),
wild-type mice made septic by CLP (n = 8), and iNOS-defi-
cient mice made septic by CLP (n = 10).
Selective iNOS inhibition
To further evaluate the role of iNOS in inflammation, leukocyte
adhesion, and microvascular leakage in sepsis, mice were
treated with the selective iNOS inhibitor 1400W. Mice were
made septic by CLP and resuscitated with fluids and antibiot-
ics as described above. 1400W (10 mg/kg) was given intra-
muscularly at the time of CLP, 6 hours later, and 12 hours later,
and videomicroscopy was then performed.
Materials
Cromolyn and 1400W were obtained from Sigma Chemical
Co. Appropriate dilutions were made with modified Krebs
solution.Available online http://ccforum.com/content/11/6/R125
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Transgenic mice deficient in iNOS were obtained from The
Jackson Laboratory (Bar Harbor, ME, USA). These mice were
shown to lack detectable iNOS mRNA and iNOS protein, and
not to produce NO (as detected by serum nitrate/nitrite levels)
after endotoxin stimulation [11].
Data analysis
Data are expressed as mean ± standard deviation, with n indi-
cating the number of animals. In each experimental animal, only
one vessel was tested. Statistical testing was done using one-
way analysis of variance for group comparisons and Tukey
HSD () honestly significantly different) for post-analysis of var-
iance comparisons or unpaired Student's t-tests for single
comparisons. P < 0.05 was deemed statstically significant.
Results
The bacteriology and mortality associated with this septic
model, which is designed to replicate the main clinical modal-
ities used in septic patients, have been reported previously;
mice become bacteremic with Gram-negative rods and anaer-
obic organisms [19]. Mortality in unresuscitated Balb/C mice
was 100%, and decreased to 80% with fluid resuscitation
only, to 72% with antibiotics only, and to 54% with both fluids
and antibiotics (P < 0.01 by Kaplan-Meier analysis) [19].
Mean arterial pressure was lower in wild-type mice after CLP
(76 ± 10 mmHg) than in sham-ligated control wild-type ani-
mals (90 ± 6 mmHg; P < 0.05). Mean arterial pressure in
iNOS-deficient control animals was 94 ± 5 mmHg, a value not
different from that of wild-type controls. Mean arterial pressure
in septic iNOS-deficient mice was 86 ± 10 mmHg, which did
not differ significantly from that of either wild-type or iNOS-
deficient controls.
Circulating white blood cell (WBC) counts were decreased in
septic wild-type mice compared with sham-operated controls
(0.9 ± 0.1 × 106 cells/ml versus 1.7 ± 0.2 × 106 cells/ml; P <
0.05). In iNOS-deficient control mice, WBC counts were
slightly but not significantly higher than in wild-type controls
(2.0 ± 0.4 × 106 cells/ml), and were also lower in septic mice
(to 1.1 ± 0.3 × 106 cells/ml, P < 0.05, versus control), but
WBC counts in iNOS-deficient septic mice did not differ sig-
nificantly compared with wild-type septic mice. Venular shear
rates were slightly higher in septic wild-type (622 ± 63 sec-
onds-1) and septic iNOS-deficient mice (661 ± 87 seconds-1)
than in wild-type (610 ± 74 seconds-1) or iNOS-deficient con-
trol mice (618 ± 87 seconds-1), but these differences were not
significant by analysis of variance (P = 0.33).
Induction of sepsis increased microvascular leukocyte rolling
in wild-type mice, from 8.5 ± 2.3 cells/minute in sham-oper-
ated controls to 61.6 ± 14.4 cells/minute in mice made septic
by CLP (P < 0.001). Rolling was increased in iNOS-deficient
control mice compared with wild-type controls (to 18.8 ± 6.9
rolling cells/minute; P = 0.048) and further increased in iNOS-
deficient septic mice (105.5 ± 30.0 cells/minute, P < 0.001,
versus both iNOS-deficient controls and wild-type septic
mice). In mice treated with the iNOS inhibitor 1400W, rolling
was 74.0 ± 13.3 cells/minute, a value significantly higher than
controls that in (P < 0.001) but not significantly different from
either wild-type or iNOS-deficient septic mice. See Figure 1.
Sepsis also increased leukocyte adhesion in wild-type mice,
from 1.1 ± 0.2 cells/100 μm per minute in sham-operated con-
trols to 4.1 ± 0.6 cells/100 μm per minute in mice made septic
by CLP (P < 0.001). Adhesion was increased in iNOS-defi-
cient control mice compared with wild-type controls (to 4.1 ±
0.1 cells/100 μm per minute; P = 0.001) and also in iNOS-
deficient septic mice (5.1 ± 0.5 cells/100 μm per minute, P <
0.001, versus wild-type septic mice, P = 0.30, versus iNOS-
deficient controls) and after iNOS inhibition with 1400W (4.9
± 0.6 cells/100 μm per minute, P < 0.001, versus wild-type
septic mice). See Figure 2.
Microvascular leakage, as assessed by leakage index, was
similarly increased with sepsis in wild-type mice, from 0.08 ±
0.01 to 0.36 ± 0.52. Despite the increased leukocyte rolling
and adhesion, microvascular leakage was not increased in
iNOS-deficient controls (0.08 ± 0.03, P = 0.99, versus wild-
type). When iNOS-deficient mice were made septic by CLP,
the increase in microvascular leakage was substantially atten-
uated (0.12 ± 0.02, P < 0.001, versus wild-type septic mice,
P = 0.08, versus iNOS-deficient controls). In mice treated with
Figure 1
Leukocyte rolling Leukocyte rolling. Shown is leukocyte rolling in wild-type control mice 
(white bar; 8.5 ± 2.3 cells/minute; n = 8), wild-type septic mice (black 
bar; 61.6 ± 14.4 cells/minute; n = 8), inducible nitric oxide synthase 
(iNOS)-deficient control mice (light stippled bar; 18.8 ± 6.9 cells/
minute; n = 8), iNOS-deficient mice (dark stippled bar; 105.5 ± 30.0; n 
= 10), and mice treated with the selective iNOS inhibitor 1400W 
(cross-hatched bar; 74.0 ± 13.3 cells/minute; n = 5). *P < 0.001 ver-
sus wild-type control. §P < 0.001 versus wild-type septic. KO, iNOS-
deficient knockout; WT, wild-type.Critical Care    Vol 11 No 6    Hollenberg et al.
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the iNOS inhibitor 1400W, leakage was also lower than in
wild-type septic mice (0.16 ± 0.05; P = 0.02), but it was sig-
nificantly higher than in sham-operated controls (P < 0.01).
See Figure 3.
Discussion
The main finding of the present study was a disjunction
between leukocyte adhesion and vascular leakage; leukocyte
rolling and adhesion was increased in septic mice both with
and without iNOS induction, but microvascular leakage in sep-
tic mice was not increased in the absence of iNOS. This find-
ing does not result from differences in circulating WBC
counts, and is not explained by differences in macrocirculatory
hemodynamic parameters, because vascular shear stress was
unchanged, and increased blood pressure would not be
expected increase the number of adherent leukocytes or
decrease leakage. This suggests an important role for iNOS in
modulating vascular permeability during sepsis independent
of effects on leukocytes. These results have both mechanistic
and therapeutic implications.
The vascular endothelium is one of the earliest targets of injury
in inflammatory states, ultimately contributing to organ dys-
function and failure. Endothelial-directed recruitment and acti-
vation of neutrophils at the site of infection to eradicate
pathogens is an important mechanism of the inflammatory
response. Upregulation of complementary adhesion mole-
cules and ligands on leukocytes and endothelial cells induced
by bacterial products and proinflammatory mediators initiates
a multistep process that includes initial contact between leu-
kocyte and endothelium, followed by a weak transient adhe-
sive interaction, manifested as leukocyte rolling, followed by
firm leukocyte adhesion to the vessel wall [20]. Firm adhesion
then allows leukocytes to transmigrate across the vessel wall
to target sites [21]. Leukocytes, upon adherence to endothe-
lial cells, become activated and generate reactive oxygen and
nitrogen species, with the potential for endothelial damage
[22]. This activation can propagate tissue injury, and its extent
is predictive of outcome [23]. Both leukocyte activation and
endothelial injury can increase microvascular permeability.
Endothelial barrier dysfunction in sepsis contributes to
decreased preload in the initial phases, and to peripheral
edema in later stages. Endothelial activation by inflammatory
mediators leads to structural changes that increase perivascu-
lar permeability and to upregulation of adhesion molecule
expression on the endothelial cell surface. Endothelial cells
form the structural barrier to capillary leakage, while proteins
such as protein kinase C and second messengers including
cGMP provide functional aspects of this barrier. Both
endothelial cell contraction, which involves actin-myosin inter-
action and changes in intracellular calcium, and passive cellu-
lar retraction, which probably involves protein kinase C
phosphorylation and actin linking at intercellular tight junctions
[24], can alter endothelial shape and can result in increased
Figure 2
Leukocyte adhesion Leukocyte adhesion. Shown is leukocyte adhesion in wild-type control 
mice (white bar; 1.1 ± 0.2 cells/100 μm per minute; n = 8), wild-type 
septic mice (black bar; 4.1 ± 0.6 cells/100 μm per minute; n = 8); 
inducible nitric oxide synthase (iNOS)-deficient control mice (light stip-
pled bar; 4.1 ± 0.1 cells/100 μm per minute; n = 8), iNOS-deficient 
mice (dark stippled bar; 5.1 ± 0.5 cells/100 μm per minute; n = 10), 
and mice treated with the selective iNOS inhibitor 1400W (cross-
hatched bar; 4.9 ± 0.6 cells/100 μm/minute; n = 5). *P < 0.001 versus 
wild-type control. KO, iNOS-deficient knockout; WT, wild-type.
Figure 3
Microvascular leakage Microvascular leakage. Shown is microvascular leakage in wild-type 
control mice (white bar; 0.08 ± 0.01; n = 8), wild-type septic mice 
(black bar; 0.36 ± 0.52; n = 8), inducible nitric oxide synthase (iNOS)-
deficient control mice (light stippled bar; 0.08 ± 0.03; n = 8), iNOS-
deficient mice (dark stippled bar; 0.12 ± 0.02; n = 10), and mice 
treated with the selective iNOS inhibitor 1400W (cross-hatched bar; 
0.16 ± 0.05; n = 5). *P < 0.001 versus wild-type control. §P < 0.001 
versus wild-type septic. KO, iNOS-deficient knockout; WT, wild-type.Available online http://ccforum.com/content/11/6/R125
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leakage. Such changes could be produced by inflammatory
mediators such as tumor necrosis factor and interleukin-1
[25], or by leukocyte adhesion, with effects on the underlying
cytoskeletal structure or activation and initiation of an oxidative
burst. Leukocyte adhesion, however, is not strictly necessary
for increased protein leakage during endotoxemia. In a study
of rats given endotoxin by continuous infusion, fucoidin, a
selectin-binding carbohydrate, blocked leukocyte adhesion
but it did not significantly decrease leakage of albumin [26]. It
seems probable that both leukocyte adhesion and circulating
mediators play a role in mediating endothelial barrier dysfunc-
tion in sepsis, possibly with a different time course.
Constitutively produced NO normally regulates leukocyte
recruitment, and its inhibition increases leukocyte rolling and
adhesion [8]. Responses to the very high levels of NO that can
be produced by iNOS are more complex and can be variable.
Leukocyte rolling is generally increased in response to endo-
toxin challenge in mice deficient in iNOS [27], although the
degree of adhesion differs in different models, with increased
adhesion in iNOS knockout mice compared with wild-type
mice with lower doses of endotoxin [27], equivalent adhesion
with high-dose endotoxin [28], and decreased adhesion in
CLP, at least in some organs [29]. The severity of the inflam-
matory insult thus appears to be an important determinant of
leukocyte responses. Experiments with chimeric mice with
either iNOS in leukocytes only (wild-type bone marrow trans-
planted into iNOS-deficient mice) or in parenchyma only
(iNOS-/- bone marrow transplanted into wild-type mice) chal-
lenged with endotoxin have revealed that in tissues other than
the lung, parenchymal cells are the principal source of iNOS
during endotoxemia, and parenchymal NOS is the dominant
source of systemic iNOS activity. In the lung, however, endo-
toxin-induced iNOS is derived largely from infiltrating leuko-
cytes [30]. As demonstrated by these studies, regional
vascular responses in sepsis and inflammation can be hetero-
geneous. In this context, our hypothesis that iNOS-deficient
septic mice would have decreased leukocyte adhesion com-
pared with wild-type septic mice was not confirmed, but our
finding of increased leukocyte rolling and equivalent leukocyte
adhesion in iNOS-deficient knockout mice was in keeping with
previous investigations. We also found increased leukocyte
adhesion in iNOS-deficient control mice. The reason for this
observation is uncertain, but it may suggest that, in the
absence of iNOS, alternative mechanisms regulate leukocyte
trafficking in response to the stress of cremaster dissection.
NO also modulates vascular permeability. Low levels of NO,
such as would be expected from activation of the constitutive
NOS isoform, in general decrease vascular permeability [31].
In fact, early nonselective inhibition of NOS after endotoxin
challenge increased vascular permeability in a rat model [32].
On the other hand, when NOS inhibition was delayed until 3
hours after endotoxin in this model, such inhibition ameliorated
the abnormal vascular leakage [32]. The idea that activation of
the constitutive NO synthase isoform is protective but that
higher levels can be damaging is a recurrent theme with par-
ticular resonance in sepsis pathogenesis; similar effects have
been postulated for vascular tone [17] as well as myocardial
contractility [33].
The findings of the present study suggest that iNOS is an
important initiator of increased vascular permeability in sepsis.
Selective iNOS inhibition with 1400W and induction of sepsis
in iNOS-deficient mice both showed reduced vascular perme-
ability without decreasing leukocyte adhesion. 1400W pro-
duced less attenuation of vascular leakage, probably because
iNOS production was not entirely abrogated, although non-
specific effects of this inhibitor cannot be excluded. Nonethe-
less, the consistency of the findings with two different
methods of attenuating iNOS production bolsters the evi-
dence for the relevance of iNOS induction to vascular leakage.
Demonstration of the importance of iNOS in a clinically rele-
vant infectious model is important because much of the previ-
ous work in rodents has been done in the inflammatory
endotoxin model. Unlike humans, rodents are resistant to
endotoxin, and use of the high doses of endotoxin necessary
to produce hypotension and mortality in mice may lead to toxic
effects not seen at the lower doses that lead to sustained
inflammatory responses in endotoxin-sensitive species such
as humans [34]. In addition, interventions that protect rodents
in models of endotoxin infusion may not be similarly protective
in models of infection such as peritonitis [35].
The study has certain limitations. Cromolyn pretreatment was
used to prevent confounding effects of mast cell degranulation
and leakage during cremaster dissection, and so the experi-
ments do not address the potential role of mast cells in medi-
ating leakage during sepsis. In addition, responses were
tested in only one vascular bed. Although cremaster videomi-
croscopy is a well studied microcirculatory model, and skeletal
muscle comprises a good portion of total body mass in mice,
some caution is warranted in extrapolating these results to
other circulations. Because only one vessel was studied in
each animal, the results also do not address regional hetero-
geneity in microvascular responses. This study was also not
designed to assess microcirculatory flow and hematocrit, both
of which may be important in sepsis; in making an assessment
of these parameters, however, regional differences would be
important, which would have necessitated a different study
design. Finally, effects of anesthesia contributing to these
observations cannot be ruled out. Inhalational isoflurane was
titrated to the minimal doses required to maintain anesthesia,
and septic mice required substantially lower doses than con-
trols, but septic mice are likely to be more susceptible to the
effects of anesthesia. The fact that vascular shear rates were
comparable in septic and control animals suggests that anes-
thetic effects were reasonably similar. In addition, inhalational
anesthetics have been shown to have anti-inflammatory
effects, particularly after ischemia and reperfusion, but alsoCritical Care    Vol 11 No 6    Hollenberg et al.
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during endotoxemia as well [36]. Because isoflurane was used
twice, for performance of CLP and then again for cremasteric
dissection, the possibility of isoflurane-induced precondition-
ing, which has been shown to influence microvascular leakage
and iNOS induction [37], cannot be excluded. The anesthetic
protocol was the same in both the septic and control groups,
however, and a robust inflammatory response was observed
with sepsis.
Conclusion
Microvascular dysfunction causing intravascular leakage of
fluid and protein contributes to hypotension and shock in sep-
sis. In a clinically relevant murine model of sepsis, we found
discordance between adhesion of leukocytes and microvascu-
lar leakage, suggesting that these are regulated independ-
ently. These findings are pertinent to the mechanisms of
vascular leakage in sepsis, and demonstrate that increased
vascular permeability in sepsis is dependent on iNOS induc-
tion, but that leukocyte activation occurs with or without iNOS.
Potential therapeutic implications include the possibility that
selective iNOS inhibition may be a more promising approach
than nonselective inhibition. The ability of NO to dilate blood
vessels, block platelet and leukocyte adhesion to endothelial
cells, and scavenge superoxide suggests that increased pro-
duction of NO during sepsis acts to maintain microvascular
blood flow and protect the endothelium from oxidative stress
and damage. Attenuation of these protective effects by nonse-
lective NOS inhibition could help explain the failure of this ther-
apy when it is applied in patients with septic shock [38].
Translation of potential salutary effects of selective iNOS inhi-
bition on vascular leakage to a measurable therapeutic benefit
would require appropriately designed clinical trials.
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